Beta Bionics, Inc. Stock-Based Compensation
Beta Bionics, Inc. (BBNX) reported Stock-Based Compensation of $12.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-29
- Beta Bionics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $7.02M, a 46.20% increase year-over-year.
- Beta Bionics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $5.41M, a 92.80% increase year-over-year.
- Beta Bionics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.30M, a 177.26% increase year-over-year.
- Beta Bionics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $4.48M, a 126.62% increase year-over-year.
- Beta Bionics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $16.38M, a 156.64% increase from fiscal 2024.
- Beta Bionics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $6.38M, a 12.83% increase from fiscal 2023.
- Beta Bionics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $5.66M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $12.42M 10-Q · filed 2026-07-29 | $16.73M derived: sum of 3 quarters · filed 2026-07-29 | $21.20M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $5.41M 10-Q · filed 2026-04-21 | $9.71M derived: sum of 2 quarters · filed 2026-04-21 | $14.19M derived: sum of 3 quarters · filed 2026-04-21 | $18.99M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.78M derived: sum of 2 quarters · filed 2026-02-24 | $13.58M derived: sum of 3 quarters · filed 2026-07-29 | $16.38M 10-K · filed 2026-02-24 |
| 2025-09-30 | $4.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $9.28M derived: sum of 2 quarters · filed 2026-07-29 | $12.08M 10-Q · filed 2025-10-28 | $13.63M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $7.60M 10-Q · filed 2026-07-29 | $9.15M derived: sum of 3 quarters · filed 2026-07-29 | $11.13M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $2.80M 10-Q · filed 2026-04-21 | $4.36M derived: sum of 2 quarters · filed 2026-04-21 | $6.33M derived: sum of 3 quarters · filed 2026-04-21 | $7.83M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.53M derived: sum of 2 quarters · filed 2026-02-24 | $5.03M derived: sum of 3 quarters · filed 2026-02-24 | $6.38M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $3.48M derived: sum of 2 quarters · filed 2025-10-28 | $4.83M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $2.86M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $1.36M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $5.66M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |